The Impact of Age and Gender on Outcomes of Patients With Advanced Renal Cell Carcinoma Treated With Targeted Therapy
Author:
Funder
Pfizer
Bayer
Harvard Cancer Center Kidney SPORE
Dana-Farber Cancer Institute
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference51 articles.
1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019
2. Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet;Armstrong;Ann Oncol,2018
3. Consideration of sex differences in medicine to improve health care and patient outcomes;Legato;JAMA,2016
4. Renal cell cancer histological subtype distribution differs by race and sex;Lipworth;BJU Int,2016
5. Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma;Hutson;Br J Cancer,2014
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Research Progress of Senile Tumor Patients with Cancer-Related Fatigue;Nursing Science;2024
2. Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC);Frontiers in Oncology;2023-03-29
3. The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Real-World Cohort Study;Cancers;2023-02-02
4. Meta-hallmarks of aging and cancer;Cell Metabolism;2023-01
5. Prognosis of clear cell renal cell carcinoma patients stratified by age: A research relied on SEER database;Frontiers in Oncology;2022-10-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3